Fonseca VA - Search Results

1

Efficacy and safety of the once-daily GLP-1 receptor agonist lixisenatide in monotherapy: a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono).

Fonseca VA, Alvarado-Ruiz R, Raccah D, Boka G, Miossec P, Gerich JE; EFC6018 GetGoal-Mono Study Investigators. Fonseca VA, et al. Diabetes Care. 2012 Jun;35(6):1225-31. doi: 10.2337/dc11-1935. Epub 2012 Mar 19. Diabetes Care. 2012. PMID: 22432104 Free PMC article. Clinical Trial.

2

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

Fonseca V, Rosenstock J, Patwardhan R, Salzman A. Fonseca V, et al. JAMA. 2000 Apr 5;283(13):1695-702. doi: 10.1001/jama.283.13.1695. JAMA. 2000. PMID: 10755495 Clinical Trial.

3

Long-term effects of troglitazone: open-label extension studies in type 2 diabetic patients.

Fonseca V, Foyt HL, Shen K, Whitcomb R. Fonseca V, et al. Diabetes Care. 2000 Mar;23(3):354-9. doi: 10.2337/diacare.23.3.354. Diabetes Care. 2000. PMID: 10868865 Clinical Trial.

4

Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes.

Desouza C, Parulkar A, Lumpkin D, Akers D, Fonseca VA. Desouza C, et al. Among authors: fonseca va. Diabetes Care. 2002 Aug;25(8):1336-9. doi: 10.2337/diacare.25.8.1336. Diabetes Care. 2002. PMID: 12145231 Clinical Trial.

5

Management of the insulin resistance syndrome.

Desouza C, Gilling L, Fonseca V. Desouza C, et al. Curr Diab Rep. 2001 Oct;1(2):140-7. doi: 10.1007/s11892-001-0026-6. Curr Diab Rep. 2001. PMID: 12643110 Review.

6

Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials.

Fonseca V, Seftel A, Denne J, Fredlund P. Fonseca V, et al. Diabetologia. 2004 Nov;47(11):1914-23. doi: 10.1007/s00125-004-1549-6. Epub 2004 Nov 25. Diabetologia. 2004. PMID: 15599697 Clinical Trial.

7

Diabetes treatments have differential effects on nontraditional cardiovascular risk factors.

Fonseca VA, Theuma P, Mudaliar S, Leissinger CA, Clejan S, Henry RR. Fonseca VA, et al. J Diabetes Complications. 2006 Jan-Feb;20(1):14-20. doi: 10.1016/j.jdiacomp.2005.05.009. J Diabetes Complications. 2006. PMID: 16389162 Clinical Trial.

8

Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes.

Fonseca V, Schweizer A, Albrecht D, Baron MA, Chang I, Dejager S. Fonseca V, et al. Diabetologia. 2007 Jun;50(6):1148-55. doi: 10.1007/s00125-007-0633-0. Epub 2007 Mar 27. Diabetologia. 2007. PMID: 17387446 Clinical Trial.

9

Identification and treatment of prediabetes to prevent progression to type 2 diabetes.

Fonseca VA. Fonseca VA. Clin Cornerstone. 2007;8(2):10-8; discussion 19-20. doi: 10.1016/s1098-3597(09)60004-1. Clin Cornerstone. 2007. PMID: 18357952 Review.

10

Management of type 2 diabetes: oral agents, insulin, and injectables.

Fonseca VA, Kulkarni KD. Fonseca VA, et al. J Am Diet Assoc. 2008 Apr;108(4 Suppl 1):S29-33. doi: 10.1016/j.jada.2008.01.047. J Am Diet Assoc. 2008. PMID: 18358251 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

352 results

Search Page